ENTO ENTERO THERAPEUTICS INC Delisting Actions 8-K Filing 2025 - Nasdaq Compliance On April 11, 2025, Entero Therapeutics, Inc. was notified by Nasdaq that it does not meet the minimum stockholders equity requirement for continued listing, reporting a negative equity of ($3,876,738) as of December 31, 2024, and must submit a compliance plan by May 26, 2025.Get access to all SEC 8-K filings of the ENTERO THERAPEUTICS INC